Your browser doesn't support javascript.
loading
Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.
Fraiman, Joseph; Erviti, Juan; Jones, Mark; Greenland, Sander; Whelan, Patrick; Kaplan, Robert M; Doshi, Peter.
Afiliação
  • Fraiman J; Thibodaux Regional Health System, Thibodaux, LA, USA. Electronic address: josephfraiman@gmail.com.
  • Erviti J; Unit of Innovation and Organization, Navarre Health Service, Spain. Electronic address: jervitil@navarra.es.
  • Jones M; Institute of Evidence-Based Healthcare, Bond University, Gold Coast, QLD, Australia. Electronic address: majones@bond.edu.au.
  • Greenland S; Fielding School of Public Health and College of Letters and Science, University of California, Los Angeles, CA, USA. Electronic address: lesdomes@g.ucla.edu.
  • Whelan P; Geffen School of Medicine, University of California, Los Angeles, CA, USA. Electronic address: PWhelan@mednet.ucla.edu.
  • Kaplan RM; Clinical Excellence Research Center, School of Medicine, Stanford University, CA, USA. Electronic address: Bob.Kaplan@stanford.edu.
  • Doshi P; School of Pharmacy, University of Maryland, Baltimore, MD, USA. Electronic address: pdoshi@rx.umaryland.edu.
Vaccine ; 40(40): 5798-5805, 2022 09 22.
Article em En | MEDLINE | ID: mdl-36055877
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / COVID-19 Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Vaccine Ano de publicação: 2022 Tipo de documento: Article País de publicação: Holanda